When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - Aevi Genomic Med up 23% after hours on Astellas deal
Astellas Pharma Inc
Nano cap Aevi Genomic Medicine (NASDAQ:GNMX) is up 23% after hours on the heels of its exclusive in-license agreement with Astellas Pharma (OTCPK:ALPMF) unit OSI Pharmaceuticals securing global development and commercialization rights to ASP7486 (formerly OSI-027).
More news on: Aevi Genomic Medicine, Inc., Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news,